Person:
YÜCESOY, TÜRKER

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
Job Title
First Name
TÜRKER
Last Name
YÜCESOY
Name
Email Address
Birth Date

Search Results

Now showing 1 - 3 of 3
  • PublicationOpen Access
    Spontaneous and Excellent Healing of Bilateral Brown Tumors in Mandible after Endocrinal Therapy and Subtotal Parathyroidectomy: Case Report with 4-Year Follow-Up
    (2018-01-01) YÜCESOY, TÜRKER; KILIÇ, ERDEM; DOĞRUEL, FATMA; BAYRAM, FAHRİ; ALKAN, ALPER; AKCAN, Alper Celal; ÖZTÜRK, FİGEN; YÜCESOY, TÜRKER; KILIÇ, ERDEM; ALKAN, ALPER
    Primary hyperparathyroidism is an endocrine disorder occurring due to increased secretion of parathormone resulting in a complex of clinical, anatomical, and biochemical alterations. On the other hand, excision of a parathyroid adenoma can normalize the metabolic status. A 24-year-old man was referred to the hospital with bilateral swelling and spontaneous gingival bleeding from posterior of the mandible also with radiolucent well-demarcated lesions bilaterally in the mandibular third molar regions. After consultations, the patient was hospitalized in the endocrinology department where further tests were performed due to highly increased PTH level as 714 pg/ml. Bilateral brown tumors started to regress spontaneously, and no additional surgery was required after subtotal parathyroidectomy was performed. The presented case is the first patient whose bilateral brown tumors in the jaws spontaneously and totally healed after subtotal parathyroidectomy and endocrinal therapy who was strictly followed up for 4 years even though the lesions were associated with impacted third molars.
  • PublicationOpen Access
    Gastrointestinal tract metastasis of mandibular diffuse large B-cell lymphoma
    (2018-09-01) YÜCESOY, TÜRKER; KILIÇ, ERDEM; Ocak, Hakan; ALKAN, ALPER; DENİZ, KEMAL; YÜCESOY, TÜRKER; KILIÇ, ERDEM; ALKAN, ALPER
    Not only diffuse large B-cell lymphoma is a malignancy, but also is initially and orally diagnosed in early stages. However, it could be misdiagnosed with other oral pathologies. However yet, early diagnosis is still crucial for the prognosis, morbidity, and mortality in such cases. Additionally, whole-body scanning with positron emission tomography/computed tomography should be performed for diagnosis and treatment process.
  • PublicationOpen Access
    Management of Patients Using Oral Anticoagulant Agent in Dental Practice
    (2019-01-01) ALKAN, ALPER; YÜCESOY, TÜRKER; DOGANAY, ÖZGE; DOĞANAY, ÖZGE; YÜCESOY, TÜRKER; ALKAN, ALPER
    An increasing number of patients in our country use oral anticoagulants for the prophylaxis and treatment of thromboembolic events. The cornerstone of these groups of agents is warfarin, a vitamin K antagonist, which has been the single alternative used by oral route for several years. However, due to warfarin's late onset and long lasting action and the intense interactions with food and drugs, newer oral anticoagulants have emerged in the market in recent years. Dabigatran, rivaroxaban and apixaban arc the novel agents used in our country. Those drugs should he regulated in the perioperative period when patients receiving oral anticoagulants are referred for dental interventions. The interruption of agents may result in lethal consequences of thromboembolic events, while continuing raises the risk of bleeding. This review outlines the various properties of the oral anticoagulants and the most recent recommendations and guidelines regarding the management of dental patients taking these medications.